Skip Navigation
Skip Website Tools

Contact Info

V. Koneti Rao, M.D.
Building 10, Room 12C106
10 Center Drive
Bethesda, MD 20814
Phone: 301-496-6502
Fax: 301-496-7383
korao@niaid.nih.gov

Study Provides Insights Into Diagnosis, Treatment of Rare Immune Disease: NIH Scientists Report Findings From 20 Years of ALPS Research

Laboratory of Immunology

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

V. Koneti Rao, M.D.

Chief, ALPS Unit, LI

Major Areas of Research

  • Autoimmune Lymphoproliferative Syndrome (ALPS), one of the first inherited autoimmune diseases whose genetic basis was defined
  • Readily available biomarkers of ALPS-like vitamin B12, IL-10, and double-negative T cells (DNT cells) providing diagnostic clues
  • Importance of apoptosis in remodeling the lymphocyte repertoire and deleting cells with autoimmune and oncogenic potential
  • Studying and understanding B-cell consequences of T-cell dysfunction leading to lymphoma, infections, and cytopenias in ALPS patients
  • Pathobiology of sporadic conditions due to immune dysfunction
  • Role of new mutations and modifier genes in health and disease
 

Program Description

Autoimmune Lymphoproliferative Syndrome (ALPS) is an inherited disorder of the immune system that affects both children and adults. In ALPS and related disorders with defective cell kill and proliferation pathways, unusually high numbers of white blood cells, called lymphocytes, accumulate in the lymph nodes, liver, and spleen, which can lead to enlargement of these organs. ALPS can also cause a variety of autoimmune problems such as anemia (low red blood cell count), thrombocytopenia (low platelets), and neutropenia (low neutrophil count). Lymphocytes infiltrating the bone marrow, lungs, liver, and brain can also lead to clinical symptoms. The ALPS Unit aims to better understand these rare diseases of lymphocyte apoptosis and immune homoeostasis, to find their genetic causes, and to uncover new ways to treat them. Its ultimate goal is to find a cure for these disorders of the immune system.

Research Group

Michael J. Lenardo, M.D.

Susan Price, R.N.

Elaine Smoot, R.N.

Morgan Butrick, ScM, Certified Genetic Counselor

Aaron Morawski, M.S., Biologist

Selected Publications

Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014 Jan 7. Epub ahead of print.

Rudman Spergel A, Walkovich K, Price S, Niemela JE, Wright D, Fleisher TA, Rao, VK. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis. Pediatrics. 2013 Nov;132(5):e1440-4.

Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood. 2011 Nov 24;118(22):5741-51.

Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome: report from the 2009 NIH International Workshop. Blood. 2010 Jun 10.

Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010 Jun 24;115(25):5164-9.

Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance. Autoimmun Rev. 2010 May;9(7):488-93.

Visit PubMed for a complete publication listing.

Last Updated January 10, 2014